Multi-laboratory validation of DNAxs including the statistical library DNAStatistX.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
11 2020
Historique:
received: 16 06 2020
revised: 30 07 2020
accepted: 26 08 2020
pubmed: 17 9 2020
medline: 14 7 2021
entrez: 16 9 2020
Statut: ppublish

Résumé

This study describes a multi-laboratory validation of DNAxs, a DNA eXpert System for the data management and probabilistic interpretation of DNA profiles [1], and its statistical library DNAStatistX to which, besides the organising laboratory, four laboratories participated. The software was modified to read multiple data formats and the study was performed prior to the release of the software to the forensic community. The first exercise explored all main functionalities of DNAxs with feedback on user-friendliness, installation and general performance. Next, every laboratory performed likelihood ratio (LR) calculations using their own dataset and a dataset provided by the organising laboratory. The organising laboratory performed LR calculations using all datasets. The datasets were generated with different STR typing kits or analysis systems and consisted of samples varying in DNA amounts, mixture ratios, number of contributors and drop-out level. Hypothesis sets had the correct, under- and over-assigned number of contributors and true and false donors as person of interest. When comparing the results between laboratories, the LRs were foremost within one unit on log10 scale. The few LR results that deviated more had differences for the parameters estimated by the optimizer within DNAStatistX. Some of these were indicated by failed iteration results, others by a failed model validation, since unrealistic hypotheses were included. When these results that do not meet the quality criteria were excluded, as is in accordance with interpretation guidelines, none of the analyses in the different laboratories yielded a different statement in the casework report. Nonetheless, changes in software parameters were sought that minimized differences in outcomes, which made the DNAStatistX module more robust. Overall, the software was found intuitive, user-friendly and valid for use in multiple laboratories.

Identifiants

pubmed: 32937255
pii: S1872-4973(20)30162-9
doi: 10.1016/j.fsigen.2020.102390
pii:
doi:

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

102390

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Corina C G Benschop (CCG)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: c.benschop@nfi.nl.

Jerry Hoogenboom (J)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: j.hoogenboom@nfi.nl.

Fiep Bargeman (F)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: f.bargeman@nfi.nl.

Pauline Hovers (P)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: p.hovers@nfi.nl.

Martin Slagter (M)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: m.slagter@nfi.nl.

Jennifer van der Linden (J)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: j.van.der.linden@nfi.nl.

Raymond Parag (R)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: r.parag@nfi.nl.

Dennis Kruise (D)

Netherlands Forensic Institute, Division of Digital and Biometric Traces, The Hague, The Netherlands. Electronic address: d.kruise@nfi.nl.

Katja Drobnic (K)

National forensic laboratory, Police, Ministry of the Interior, Ljubljana, Slovenia. Electronic address: katja.drobnic@policija.si.

Gregor Klucevsek (G)

National forensic laboratory, Police, Ministry of the Interior, Ljubljana, Slovenia. Electronic address: gregor.kljucevsek@policija.si.

Walther Parson (W)

Institute of Legal Medicine, Medical University of Innsbruck, Austria; Forensic Science Program, The Pennsylvania State University, University Park, PA, USA. Electronic address: Walther.parson@i-med.ac.at.

Burkhard Berger (B)

Institute of Legal Medicine, Medical University of Innsbruck, Austria. Electronic address: Burkhard.berger@i-med.ac.at.

Francois Xavier Laurent (FX)

Institut National de Police Scientifique, Ecully, France. Electronic address: fx.laurent@interpol.int.

Magalie Faivre (M)

Institut National de Police Scientifique, Ecully, France. Electronic address: magalie.faivre@interieur.gouv.fr.

Ayhan Ulus (A)

Institut National de Police Scientifique, Ecully, France. Electronic address: ayhan.ulus@interieur.gouv.fr.

Peter Schneider (P)

Institute of Legal Medicine, University Hospital of Cologne, Division of Forensic Molecular Genetics, Cologne, Germany. Electronic address: peter.schneider@uk-koeln.de.

Magdalena Bogus (M)

Institute of Legal Medicine, University Hospital of Cologne, Division of Forensic Molecular Genetics, Cologne, Germany. Electronic address: magdalena.bogus@uk-koeln.de.

Alexander L J Kneppers (ALJ)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: s.kneppers@nfi.nl.

Titia Sijen (T)

Netherlands Forensic Institute, Division of Biological Traces, Laan van Ypenburg 6, 2497GB, The Hague, The Netherlands. Electronic address: t.sijen@nfi.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH